Isoniazid

A Study of Daily Rifapentine Combined With Isoniazid (1HP) for Tuberculosis Prevention in Children Less Than 13 Years of Age With and Without HIV

Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis

Shortened Regimen for Drug-susceptible TB in Children

Study of Limited Versus Continuous Isoniazid Tuberculosis Preventive Therapy in HIV-infected Persons in Botswana

Safety and Efficacy Evaluation of 4-month Regimen of OPC-167832, Delamanid and Bedaquiline in Participants With Drug-Susceptible Pulmonary TB

Trial of Novel Regimens for the Treatment of Pulmonary Tuberculosis

A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)

Tuberculosis Clinical Trials Consortium Study 35

Safety and Tolerability of Metformin in People With Tuberculosis (TB) and Human Immunodeficiency Virus (HIV)

An Adaptive Multi-arm Trial to Improve Clinical Outcomes Among Children Recovering From Complicated SAM

Ultra-Short Course Bedaquiline, Clofazimine, Pyrazinamide and Delamanid Versus Standard Therapy for Drug-Susceptible TB

Addiction, HIV and Tuberculosis in Malaysian Criminal Justice Settings

Phase I Open Label BCG Clinical Trial Assessing TB Drugs and Vaccines

Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIV

Pharmacokinetic Study of Antiretroviral Drugs and Related Drugs During and After Pregnancy

PanACEA - STEP2C -01

Short-course Regimens for the Treatment of Pulmonary Tuberculosis

Pharmacokinetic and Pharmacodynamic Study of High-Dose Rifapentine and Moxifloxacin for Treatment of Tuberculosis

Clofazimine- and Rifapentine-Containing Treatment Shortening Regimens in Drug-Susceptible Tuberculosis: The CLO-FAST Study

Short-Course Anti-tuberculosis Regimens for Mild Spinal Tuberculosis